FDA Approved: GEMFIBROZIL — Original Application (Cadila Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Cadila Pharmaceuticals Limited's original ANDA for gemfibrozil, authorizing a generic version of the lipid-lowering drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Gemfibrozil (Gemfibrozil)

Snippet

ORIG AP for GEMFIBROZIL (GEMFIBROZIL)